With commercial orders landing and medical device applications ramping up, Ilika plc (LON:IKA) latest half-year results show solid progress on both their Stereax and Goliath battery programmes. CEO Graeme Purdy outlines how production has now moved into customer delivery, with Cirtec Medical playing a key role in scaling the Stereax line. He also pushes back on the media’s EV pessimism, highlighting UK growth and a strategic push to differentiate from commoditised Chinese batteries. Investors will want to hear what’s next — including a potential leap to a 50 amp hour prototype and an integrated platform offering for OEMs.
Key Moments:
- [00:21] – Introduction and Stereax production update
- [01:20] – First commercial order confirmed
- [01:55] – Stereax use cases: from neurostimulators to smart orthopaedics
- [03:02] – Upcoming milestone: Cirtec integration platform
- [04:07] – EV growth in the UK and Ilika’s positioning vs Chinese competitors
- [05:36] – Goliath’s PRIMED project and UK partnerships (JLR, UKBIC, Oxford)
- [06:31] – Delivery of 10Ah prototype and next steps towards MVP
Ilika Plc is a pioneer in solid state battery technology, enabling solutions for applications such as Industrial IoT, MedTech, Electric Vehicals and Consumer Electronics.
